NASDAQ:CYAD

Celyad Oncology Earning Date

USA |NASDAQ |USD |ADR

CYAD Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
- Jun 30, 2020 - $-0.67 -
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
- Jun 30, 2020 - - $0.00

CYAD Earnings Date & History Chart

CYAD Earnings & Revenue Forecast

CYAD Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast

CYAD Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend

CYAD Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast

CYAD Earnings Date & Revenue History

CYAD Earnings History

|
Show More
Show More

CYAD Revenue History

|
Show More
Show More

Celyad Oncology Next Earnings Date & Report

CYAD Jun 2020 (FQ) Earnings Date & Report Preview

Celyad Oncology Previous Earnings Dates & Reports

CYAD Previous Earnings Date & Report Recap: Mar 2020 (FQ)

Celyad Oncology's previous earnings date was Jun 30, 2020 for its fiscal quarter ended Mar 31, 2020.

CYAD's earnings per share (EPS) was $-0.67.

The EPS was lower than the previous fiscal quarter (Dec 2019) by 1.97%.

CYAD Previous Earnings Date & Report Recap: Dec 2020 (FY)

Revenues were $5.00K, down by -16.67% from previous year's revenue.

The company reported a net income of $-17.20M.

Celyad Oncology reported a free cash flow of $-27.98M for its fiscal year, compared to $-28.82M a year ago.

The company ended the fiscal year with $3.64M in total debt, an increase of 160.60% compared to the previous year.